Literature DB >> 17343300

Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis.

Michael A Mont, Slif D Ulrich, Thorsten M Seyler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17343300

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

Review 1.  Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy.

Authors:  Waqar Haque; Huseyin Kadikoy; Omar Pacha; Joseph Maliakkal; Vu Hoang; Abdul Abdellatif
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

2.  Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes.

Authors:  Kazutaka Sakamoto; Makoto Osaki; Akira Hozumi; Hisataka Goto; Tatsuya Fukushima; Hideo Baba; Hiroyuki Shindo
Journal:  BMC Musculoskelet Disord       Date:  2011-04-27       Impact factor: 2.362

3.  The role of hypercoagulability in the development of osteonecrosis of the femoral head.

Authors:  Marios G Lykissas; Ioannis D Gelalis; Ioannis P Kostas-Agnantis; Georgios Vozonelos; Anastasios V Korompilias
Journal:  Orthop Rev (Pavia)       Date:  2012-05-29

4.  Salmonella osteomyelitis complicating aseptic osteonecrosis: Don't forget about the antiphospholipid syndrome.

Authors:  Fatma Daoud; Imène Rachdi; Olfa Frikha; Mohamed Ben Salah; Soumaya Charaa; Hana Zoubeidi; Mehdi Somai; Khaled Hadhri; Mondher Kooli; Chiraz Chammakhi; Fatma Boussema
Journal:  Clin Case Rep       Date:  2021-03-11

5.  Avascular necrosis of the femoral head due to the bilateral injection of heroin into the femoral vein: A case report.

Authors:  Dengke Wu; Deye Song; Jiangdong Ni; Ruchun Dai
Journal:  Exp Ther Med       Date:  2013-07-26       Impact factor: 2.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.